17beta-hydroxysteroid dehydrogenase type 13 (HSD17b13) iRNA compositions and methods of use thereof

• 收藏
• 分享

专利权人:

Regeneron Pharmaceuticals; Inc.

发明人:

HINKLE, Gregory,TREMBLAY, Frederic,ABUL-HUSN, Noura, S.,GOTTESMAN, Omri,LI, Alexander,CHENG, Xiping,XIN, Yurong,GROMADA, Jesper,DEWEY, Frederick, E.,BARAS, Aris,SHULDINER, Alan,MILSTEIN, Stuart

申请号：

AU2019239971

公开号：

AU2019239971A1

申请日:

2019.03.20

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the HSD17B 13 gene, as well as methods of inhibiting epression of HSD17B13, and methods of treating subjects that would benefit from reduction in expression of HSD17B13, such as subjects having a HSD17B13-associated disease, disorder, or condition, using such dsRNA compositions.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/